SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SRX Global Updates Engineered T-Cell Strategy

SRX Global provided an update on its engineered T-cell strategy following the Pfizer–Starna licensing agreement.

CEROSRXH

Related stories